Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Regulatory News

Date Source Headline
20th May 2024 7:00 am RNS Holding(s) in Company
14th May 2024 2:55 pm RNS Holding(s) in Company
8th May 2024 7:05 am RNS Filing of Form 10-Q
8th May 2024 7:00 am RNS First Quarter Results
3rd May 2024 7:00 am RNS Notice of AGM
1st May 2024 5:04 pm RNS Total Voting Rights
10th Apr 2024 1:05 pm RNS Notice of Results
3rd Apr 2024 7:00 am RNS Total Voting Rights and Block Listing Return
2nd Apr 2024 1:05 pm RNS Signing of Strategic Platform License
2nd Apr 2024 7:00 am RNS Exercise of options and PDMR dealing
20th Mar 2024 10:16 am RNS Grant of Options, RSUs and PSUs and PDMR Dealing
20th Mar 2024 10:05 am RNS Grant of Options, RSUs and PSUs and PDMR Dealing
13th Mar 2024 7:05 am RNS Filing of form 10-K for FY ended December 31, 2023
13th Mar 2024 7:00 am RNS Reports Q4 & FY 2023 Financial Results
6th Mar 2024 8:58 am RNS TR-1: Notification of major holdings
5th Mar 2024 7:00 am RNS Preliminary FY Results & 2024 Guidance
1st Mar 2024 5:57 pm RNS Total Voting Rights
29th Feb 2024 9:21 am RNS Exercise of options and PDMR dealing
26th Feb 2024 7:00 am RNS TR-1: Notification of major holdings
9th Feb 2024 1:05 pm RNS Notice of Results
1st Feb 2024 9:24 am RNS Total Voting Rights
31st Jan 2024 7:00 am RNS Director/PDMR Shareholding
30th Jan 2024 2:29 pm RNS Holding(s) in Company
30th Jan 2024 1:05 pm RNS Signing of Strategic Platform License
29th Jan 2024 4:52 pm RNS TR-1: Notification of major holdings
29th Jan 2024 7:00 am RNS Filing of Form 8-K
23rd Jan 2024 1:05 pm RNS Signing of Strategic Platform License
9th Jan 2024 7:00 am RNS Preliminary Unaudited Q4 and FY 2023 Results
5th Jan 2024 7:00 am RNS Grant of Options and PDMR Dealing
3rd Jan 2024 1:05 pm RNS Signing of Strategic Platform License
2nd Jan 2024 9:23 am RNS Total Voting Rights
2nd Jan 2024 7:00 am RNS Confirmation of Board change
29th Dec 2023 7:00 am RNS Exercise of options and PDMR dealing
12th Dec 2023 7:00 am RNS CEO Transition and Revenue Guidance Update
7th Dec 2023 9:50 am RNS Exercise of options and PDMR dealing
4th Dec 2023 7:00 am RNS Exercise of options and PDMR dealing
1st Dec 2023 5:43 pm RNS Total Voting Rights
30th Nov 2023 7:00 am RNS Exercise of options and PDMR dealing
17th Nov 2023 7:00 am RNS Exercise of options and PDMR dealing
16th Nov 2023 1:05 pm RNS MaxCyte Joins the Alliance for mRNA Medicines
FTSE 100 Latest
Value8,275.66
Change0.00